This study, conducted at a major Chinese hospital, shifts the spotlight from the Intensive Care Unit (ICU) to general hospital wards to track the silent spread of "superbugs." By analyzing over 1,100 multidrug-resistant organism (MDRO) strains, the researchers discovered that nearly two-thirds of these infections are "imported" into non-ICU departments via patient transfers or community admission, rather than originating within the wards themselves.
TL;DR
While ICUs are the traditional focus of antibiotic resistance research, this study reveals that non-ICU departments are significant reservoirs for multidrug-resistant organisms (MDROs), with nearly 60% of infections originating outside the hospital. The findings highlight that patient mobility—both between facilities and between internal wards—is a primary driver of MDRO distribution, necessitating more robust screening during patient transfers.
What Problem Does This Paper Address?
Multidrug-resistant organisms (MDROs) like MRSA and CRE are a global health crisis, leading to higher mortality and massive medical expenses. Historically, research has focused on the ICU, where patients are most vulnerable and invasive procedures are common. However, as patients move more frequently between departments and hospitals, MDROs are increasingly appearing in "lower-risk" non-ICU wards.
The authors tackle a critical gap: we don't fully understand the distribution or the source of these infections in general wards. Are patients catching these bugs in the ward, or are they bringing them in from the community or other hospitals? Answering this is vital for designing targeted infection control protocols.
Methods
The researchers conducted a retrospective study at The First Affiliated Hospital with Nanjing Medical University, analyzing data from October 2017 to September 2019.
- Surveillance: They used the "Xinglin-tech" Nosocomial Infections Surveillance System to recruit 802 patients and isolate 1,116 MDRO strains.
- Source Categorization: A key novel aspect of this study was the granular classification of infection sources into four groups:
- Out-of-hospital transfer: Patients coming from other medical facilities.
- Community-acquired: Patients coming from home with no recent hospitalization.
- In-hospital transfer: Patients moved from other departments (like the ICU) within the same hospital.
- Department-acquired: Infections that developed specifically within the non-ICU ward after admission.
- Identification: Strains were identified using the VITEK-2Compact system, with drug sensitivity interpreted according to 2019 CLSI standards.
Datasets
The study utilized a primary clinical dataset of 1,116 MDRO strains isolated from 802 patients in non-ICU departments. The specific organisms tracked included:
- CRE: Carbapenem-resistant Enterobacteriaceae
- MRSA: Methicillin-resistant Staphylococcus aureus
- CRAB: Carbapenem-resistant Acinetobacter baumannii
- CRPA: Carbapenem-resistant Pseudomonas aeruginosa
Key Insights and Ideas
- The "Import" Phenomenon: The most striking finding is that non-ICU wards are often recipients of MDROs rather than the primary source. About 57% of infections were "out-of-hospital," and when including internal transfers, nearly 2/3 of cases were imported.
- Departmental Hotspots: Geriatric medicine (13.17%), neurosurgery (10.04%), and rehabilitation (8.51%) were the top departments for MDROs. These wards typically house patients with longer stays and more complex care needs, making them high-traffic zones for resistant bacteria.
- Site-Specific Vulnerability: The lower respiratory tract was the most common infection site (48.39%), followed by surgical sites and the urinary tract. This suggests that even in non-ICU settings, respiratory care remains a critical frontier for infection control.
- CRE is the New Frontline: In this cohort, CRE (34.41%) was more prevalent than MRSA (29.66%), highlighting the growing threat of carbapenem resistance in general medicine.
Key Results
- Source Breakdown: 57.44% of infections were out-of-hospital (33.42% transfers, 24.01% community). 42.56% were nosocomial (4.66% internal transfers, 37.90% department-acquired).
- Detection Rates: While non-ICU MDRO detection rates were significantly lower than hospital-wide averages (which include the ICU), they remain high. For example, the MRSA detection rate in non-ICU wards was 43.83%, compared to 51.48% for the whole hospital.
- Statistical Significance: There were significant differences ($P < 0.001$) in how different MDROs were distributed across departments. For instance, CRE was particularly high in hepatobiliary and pancreaticobiliary centers (over 50% of their MDRO cases).
Limitations and Future Work
- Single-Center Study: The data comes from one large hospital in Nanjing, which may not reflect MDRO dynamics in smaller community hospitals or different geographic regions.
- Retrospective Design: The study relies on existing records; a prospective study could provide more real-time data on transmission pathways.
- Colonization vs. Infection: While the authors excluded "repetitive strains," distinguishing between true infection and asymptomatic colonization remains a challenge in large-scale surveillance.
- Future Directions: The authors suggest implementing automated "MDRO alerts" within hospital information systems to flag high-risk patients during transfers. They also emphasize the need for better post-discharge follow-up to prevent MDRO carriers from spreading bacteria back into the community.
Summary updated